Literature DB >> 22619368

Oral contraceptives, reproductive factors and risk of inflammatory bowel disease.

Hamed Khalili1, Leslie M Higuchi, Ashwin N Ananthakrishnan, James M Richter, Diane Feskanich, Charles S Fuchs, Andrew T Chan.   

Abstract

BACKGROUND: Oral contraceptive use has been associated with risk of Crohn's disease (CD) and ulcerative colitis (UC).
OBJECTIVE: To determine whether this association is confounded or modified by other important lifestyle and reproductive factors.
DESIGN: A prospective cohort study was carried out of 117,375 US women enrolled since 1976 in the Nurses Health Study I (NHS I) and 115,077 women enrolled since 1989 in the Nurses' Health Study II (NHS II) with no prior history of UC or CD. These women had provided information every 2 years, on age at menarche, oral contraceptive use, parity, menopause status and other risk factors. Diagnoses of CD and UC were confirmed by review of medical records. Cox proportional hazards models were used to calculate HRs and 95% CIs.
RESULTS: Among 232,452 women with over 5,030,196 person-years of follow-up, 315 cases of CD and 392 cases of UC were recorded through 2007 in NHS II and 2008 in NHS I. Compared with never users of oral contraceptives, the multivariate-adjusted HRs for CD were 2.82 (95% CI 1.65 to 4.82) among current users and 1.39 (95% CI 1.05 to 1.85) among past users. The association between oral contraceptives and UC differed according to smoking history (pheterogeneity=0.04). Age at menarche, age at first birth and parity were not associated with risk of UC or CD.
CONCLUSION: In two large prospective cohorts of US women, oral contraceptive use was associated with risk of CD. The association between oral contraceptive use and UC was limited to women with a history of smoking.

Entities:  

Keywords:  Crohn's colitis; Crohn's disease; IBD clinical; Inflammatory bowel disease; Nurses' Health Study; adenocarcinoma; adenoma; aspirin; cancer epidemiology; cancer prevention; chemoprevention; cyclooxygenase-2; epidemiology; gastrointestinal haemorrhage; health service research; inflammation; non-steroidal anti-inflammatory drugs; oral contraceptive use; reproductive factors; ulcerative colitis

Mesh:

Substances:

Year:  2012        PMID: 22619368      PMCID: PMC3465475          DOI: 10.1136/gutjnl-2012-302362

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  41 in total

1.  Assessment of the diagnoses of Crohn's disease and ulcerative colitis in a Danish hospital information system.

Authors:  K Fonager; H T Sørensen; S N Rasmussen; J Møller-Petersen; M Vyberg
Journal:  Scand J Gastroenterol       Date:  1996-02       Impact factor: 2.423

2.  A study of the menopause, smoking, and contraception in women with Crohn's disease.

Authors:  A Lichtarowicz; C Norman; B Calcraft; J S Morris; J Rhodes; J Mayberry
Journal:  Q J Med       Date:  1989-07

3.  Geographical variation and incidence of inflammatory bowel disease among US women.

Authors:  Hamed Khalili; Edward S Huang; Ashwin N Ananthakrishnan; Leslie Higuchi; James M Richter; Charles S Fuchs; Andrew T Chan
Journal:  Gut       Date:  2012-01-11       Impact factor: 23.059

4.  Risk factors for inflammatory bowel disease in the general population.

Authors:  L A García Rodríguez; A González-Pérez; S Johansson; M-A Wallander
Journal:  Aliment Pharmacol Ther       Date:  2005-08-15       Impact factor: 8.171

5.  Oral contraceptive use and cigarette smoking in Crohn's disease.

Authors:  B Katschinski; D Fingerle; B Scherbaum; H Goebell
Journal:  Dig Dis Sci       Date:  1993-09       Impact factor: 3.199

6.  Ulcerative colitis in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival.

Authors:  E V Loftus; M D Silverstein; W J Sandborn; W J Tremaine; W S Harmsen; A R Zinsmeister
Journal:  Gut       Date:  2000-03       Impact factor: 23.059

7.  Environmental risk factors and Crohn's disease: a population-based, case-control study in Spain.

Authors:  B Sicilia; C López Miguel; F Arribas; J López Zaborras; E Sierra; F Gomollón
Journal:  Dig Liver Dis       Date:  2001-12       Impact factor: 4.088

8.  Nonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis.

Authors:  Ivan J Fuss; Frank Heller; Monica Boirivant; Francisco Leon; Masaru Yoshida; Stefan Fichtner-Feigl; Zhiqiong Yang; Mark Exley; Atsushi Kitani; Richard S Blumberg; Peter Mannon; Warren Strober
Journal:  J Clin Invest       Date:  2004-05       Impact factor: 14.808

Review 9.  Risk of venous thromboembolic disease associated with hormonal contraceptives and hormone replacement therapy: a clinical review.

Authors:  Marcelo P V Gomes; Steven R Deitcher
Journal:  Arch Intern Med       Date:  2004-10-11

10.  Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47.

Authors:  Carl A Anderson; Gabrielle Boucher; Charlie W Lees; Andre Franke; Mauro D'Amato; Kent D Taylor; James C Lee; Philippe Goyette; Marcin Imielinski; Anna Latiano; Caroline Lagacé; Regan Scott; Leila Amininejad; Suzannah Bumpstead; Leonard Baidoo; Robert N Baldassano; Murray Barclay; Theodore M Bayless; Stephan Brand; Carsten Büning; Jean-Frédéric Colombel; Lee A Denson; Martine De Vos; Marla Dubinsky; Cathryn Edwards; David Ellinghaus; Rudolf S N Fehrmann; James A B Floyd; Timothy Florin; Denis Franchimont; Lude Franke; Michel Georges; Jürgen Glas; Nicole L Glazer; Stephen L Guthery; Talin Haritunians; Nicholas K Hayward; Jean-Pierre Hugot; Gilles Jobin; Debby Laukens; Ian Lawrance; Marc Lémann; Arie Levine; Cecile Libioulle; Edouard Louis; Dermot P McGovern; Monica Milla; Grant W Montgomery; Katherine I Morley; Craig Mowat; Aylwin Ng; William Newman; Roel A Ophoff; Laura Papi; Orazio Palmieri; Laurent Peyrin-Biroulet; Julián Panés; Anne Phillips; Natalie J Prescott; Deborah D Proctor; Rebecca Roberts; Richard Russell; Paul Rutgeerts; Jeremy Sanderson; Miquel Sans; Philip Schumm; Frank Seibold; Yashoda Sharma; Lisa A Simms; Mark Seielstad; A Hillary Steinhart; Stephan R Targan; Leonard H van den Berg; Morten Vatn; Hein Verspaget; Thomas Walters; Cisca Wijmenga; David C Wilson; Harm-Jan Westra; Ramnik J Xavier; Zhen Z Zhao; Cyriel Y Ponsioen; Vibeke Andersen; Leif Torkvist; Maria Gazouli; Nicholas P Anagnou; Tom H Karlsen; Limas Kupcinskas; Jurgita Sventoraityte; John C Mansfield; Subra Kugathasan; Mark S Silverberg; Jonas Halfvarson; Jerome I Rotter; Christopher G Mathew; Anne M Griffiths; Richard Gearry; Tariq Ahmad; Steven R Brant; Mathias Chamaillard; Jack Satsangi; Judy H Cho; Stefan Schreiber; Mark J Daly; Jeffrey C Barrett; Miles Parkes; Vito Annese; Hakon Hakonarson; Graham Radford-Smith; Richard H Duerr; Séverine Vermeire; Rinse K Weersma; John D Rioux
Journal:  Nat Genet       Date:  2011-02-06       Impact factor: 38.330

View more
  75 in total

Review 1.  Long-term intake of dietary fat and risk of ulcerative colitis and Crohn's disease.

Authors:  Ashwin N Ananthakrishnan; Hamed Khalili; Gauree G Konijeti; Leslie M Higuchi; Punyanganie de Silva; Charles S Fuchs; Walter C Willett; James M Richter; Andrew T Chan
Journal:  Gut       Date:  2013-07-04       Impact factor: 23.059

2.  Coincidence of active Crohn's disease and florid endometriosis in the terminal ileum: a case report.

Authors:  Elke Kaemmerer; Maren Westerkamp; Reinhard Kasperk; Gerhard Niepmann; Axel Scherer; Nikolaus Gassler
Journal:  World J Gastroenterol       Date:  2013-07-21       Impact factor: 5.742

3.  Association Between Long-term Oral Contraceptive Use and Risk of Crohn's Disease Complications in a Nationwide Study.

Authors:  Hamed Khalili; Fredrik Granath; Karin E Smedby; Anders Ekbom; Martin Neovius; Andrew T Chan; Ola Olen
Journal:  Gastroenterology       Date:  2016-02-23       Impact factor: 22.682

Review 4.  Epidemiology and risk factors for IBD.

Authors:  Ashwin N Ananthakrishnan
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-03-03       Impact factor: 46.802

5.  Impaired estrogen signaling underlies regulatory T cell loss-of-function in the chronically inflamed intestine.

Authors:  Wendy A Goodman; Sarah M Bedoyan; Hannah L Havran; Brian Richardson; Mark J Cameron; Theresa T Pizarro
Journal:  Proc Natl Acad Sci U S A       Date:  2020-07-06       Impact factor: 11.205

6.  Editorial: Statins for Inflammatory Bowel Disease: Expanding the Scope of Prevention.

Authors:  Hamed Khalili
Journal:  Am J Gastroenterol       Date:  2016-10       Impact factor: 10.864

Review 7.  Challenges in designing a national surveillance program for inflammatory bowel disease in the United States.

Authors:  Millie D Long; Susan Hutfless; Michael D Kappelman; Hamed Khalili; Gilaad G Kaplan; Charles N Bernstein; Jean Frederic Colombel; Corinne Gower-Rousseau; Lisa Herrinton; Fernando Velayos; Edward V Loftus; Geoffrey C Nguyen; Ashwin N Ananthakrishnan; Amnon Sonnenberg; Andrew Chan; Robert S Sandler; Ashish Atreja; Samir A Shah; Kenneth J Rothman; Neal S Leleiko; Renee Bright; Paolo Boffetta; Kelly D Myers; Bruce E Sands
Journal:  Inflamm Bowel Dis       Date:  2014-02       Impact factor: 5.325

Review 8.  Environmental triggers for inflammatory bowel disease.

Authors:  Ashwin N Ananthakrishnan
Journal:  Curr Gastroenterol Rep       Date:  2013-01

9.  Identification of Menopausal and Reproductive Risk Factors for Microscopic Colitis-Results From the Nurses' Health Study.

Authors:  Kristin E Burke; Ashwin N Ananthakrishnan; Paul Lochhead; Po-Hong Liu; Ola Olen; Jonas F Ludvigsson; James M Richter; Shelley S Tworoger; Andrew T Chan; Hamed Khalili
Journal:  Gastroenterology       Date:  2018-08-23       Impact factor: 22.682

Review 10.  Risk of Inflammatory Bowel Disease with Oral Contraceptives and Menopausal Hormone Therapy: Current Evidence and Future Directions.

Authors:  Hamed Khalili
Journal:  Drug Saf       Date:  2016-03       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.